Effects of interleukin-4 administration on endocrine function and lipid profile of patients with malignant diseases

Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.

Breast (Edinburgh, Scotland)·2007

Osteosarcoma of bone in apatient with primary hyperparathyroidism: a case report.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2003

Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report.

Medical oncology (Northwood, London, England)·2002

Adrenocortical carcinoma. Clinical outcome at the end of the 20th century.

Cancer·2001

Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach.

Pediatrics·2001

Interplay of pregnancy, lactation, and hyperthyroidism leading to severe osteoporosis in a young woman.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2001

You Are Already Trained for This: The Hematologist/Oncologist's Role in Radiation Mass Casualty Response.

Blood·2026

Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia.

Blood·2026

Multipotent Progenitor-3 Cells Are Reprogrammed by Bone-derived DKK1 to Drive Myelopoiesis in Breast Cancer.

Blood·2026

Characterization of disease-initiating hematopoietic stem cells in calreticulin-mutated myeloproliferative neoplasms.

Blood·2026

HIF-1α/ADPGK-driven glycolytic reprogramming provokes platelet hyperactivation by fueling RHOA lactylation.

Blood·2026

Development of Inno8, an orally administered factor VIIIa-mimetic antibody fragment for treatment of hemophilia A.

Blood·2026

A scalable outpatient framework for BI-RADS 2-4B breast nodule management: an iodine-DMSO transdermal protocol.

Frontiers in health services·2026

Spontaneous rupture of the urinary bladder and hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a case report.

Journal of surgical case reports·2026

Related Experiment Videos

Effects of interleukin-4 administration on endocrine function and lipid profile of patients with malignant diseases

Related Concept Videos

Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.

Osteosarcoma of bone in apatient with primary hyperparathyroidism: a case report.

Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report.

Adrenocortical carcinoma. Clinical outcome at the end of the 20th century.

Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach.

Interplay of pregnancy, lactation, and hyperthyroidism leading to severe osteoporosis in a young woman.

You Are Already Trained for This: The Hematologist/Oncologist's Role in Radiation Mass Casualty Response.

Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia.

Multipotent Progenitor-3 Cells Are Reprogrammed by Bone-derived DKK1 to Drive Myelopoiesis in Breast Cancer.

Characterization of disease-initiating hematopoietic stem cells in calreticulin-mutated myeloproliferative neoplasms.

HIF-1α/ADPGK-driven glycolytic reprogramming provokes platelet hyperactivation by fueling RHOA lactylation.

Development of Inno8, an orally administered factor VIIIa-mimetic antibody fragment for treatment of hemophilia A.

A scalable outpatient framework for BI-RADS 2-4B breast nodule management: an iodine-DMSO transdermal protocol.

Spontaneous rupture of the urinary bladder and hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a case report.

Related Experiment Videos

Effects of interleukin-4 administration on endocrine function and lipid profile of patients with malignant diseases

Related Concept Videos

Related Articles